Literature DB >> 12707011

Alveolar wall apoptosis causes lung destruction and emphysematous changes.

Kazutetsu Aoshiba1, Naoko Yokohori, Atsushi Nagai.   

Abstract

Pulmonary emphysema is characterized by alveolar wall destruction and airspace enlargement. Recent evidence indicates that epithelial or endothelial apoptosis may be involved in the pathogenesis of emphysema. Here, we describe the induction of emphysematous changes, including airspace enlargement, alveolar wall destruction, and enhanced lung distensibility, in mice receiving a single intratracheal injection of active caspase-3 and Chariot, a newly developed protein transfection reagent. Epithelial apoptosis and enhanced elastolytic activity (optimal at pH 5.5) in bronchoalveolar lavage were noted. Emphysematous changes were also generated in mice receiving an intratracheal injection of nodularin, a proapoptotic serine/threonine kinase inhibitor. This murine model provides direct evidence that confirms that alveolar wall apoptosis causes emphysematous changes. Furthermore, this simple technique for protein transfection of lung tissue can be used in a variety of future applications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707011     DOI: 10.1165/rcmb.2002-0090OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  119 in total

1.  Dual function inhibitors of relevance to chronic obstructive pulmonary disease.

Authors:  Dengfeng Dou; Guijia He; Kevin R Alliston; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2010-12-10       Impact factor: 2.823

Review 2.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

3.  Probing potassium channel function in vivo by intracellular delivery of antibodies in a rat model of retinal neurodegeneration.

Authors:  Dorit Raz-Prag; William N Grimes; Robert N Fariss; Camasamudram Vijayasarathy; Maria M Campos; Ronald A Bush; Jeffrey S Diamond; Paul A Sieving
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

4.  Effects of structure on inhibitory activity in a series of mechanism-based inhibitors of human neutrophil elastase.

Authors:  Dengfeng Dou; Guijia He; Rongze Kuang; Qingfong Fu; Radhika Venkataraman; William C Groutas
Journal:  Bioorg Med Chem       Date:  2010-08-05       Impact factor: 3.641

5.  Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection.

Authors:  Tsuyoshi Umehara; Kosuke Kato; Yong Sung Park; Erik P Lillehoj; Hideyuki Kawauchi; Kwang Chul Kim
Journal:  Inflamm Res       Date:  2012-05-29       Impact factor: 4.575

Review 6.  Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.

Authors:  Tzipora Goldkorn; Simone Filosto; Samuel Chung
Journal:  Antioxid Redox Signal       Date:  2014-07-01       Impact factor: 8.401

Review 7.  Conceptual approaches to lung injury and repair.

Authors:  Rachel L Zemans; Peter M Henson; Jan E Henson; William J Janssen
Journal:  Ann Am Thorac Soc       Date:  2015-03

8.  Selenoprotein N deficiency in mice is associated with abnormal lung development.

Authors:  Behzad Moghadaszadeh; Branden E Rider; Michael W Lawlor; Martin K Childers; Robert W Grange; Kushagra Gupta; Steve S Boukedes; Caroline A Owen; Alan H Beggs
Journal:  FASEB J       Date:  2013-01-16       Impact factor: 5.191

Review 9.  Cell Death in the Lung: The Apoptosis-Necroptosis Axis.

Authors:  Maor Sauler; Isabel S Bazan; Patty J Lee
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

Review 10.  Animal models of chronic obstructive pulmonary disease.

Authors:  Joanne L Wright; Manuel Cosio; Andrew Churg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.